Novartis Investigative Site

Harrow HA1 3UJ

0 studies enrolling now · 6 studies all time

What they study most

Alzheimer's Disease, Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure (CHF), Cytokine Storm (Covid-19), Heart Failure With Reduced Ejection Fraction, Lymphoma, Follicular

Studies at this site

• Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm — Completed
• Ofatumumab Bendamustine Combination Compared With Bendamustine Monotherapy in Indolent B-cell NHL Unresponsive to Rituxtherapy — Stopped early
• Dose-ranging Safety and Tolerability Study in Subjects ≥60 Years of Age — Completed
• Safety and Tolerability of Initiating LCZ696 in Heart Failure Patients — Completed